Larimar Therapeutics, Inc. LRMR 深 沪
已收盘 08-14 16:00:00 美东时间
4.36
+0.090
+2.11%
华盛通- 最 高4.39
- 今 开4.26
- 成交量 118.31万股
- 最 低 4.17
- 昨 收 4.27
- 总市值 4.53亿
- 52周最高 6.42
- 市盈率 静 --
- 换手率 1.14%
- 52周最低 2.715
- 委 比 -70.63%
- 总股本 1.04亿
- 历史最高 664.32
- 量 比 0.93
- 振 幅 5.15%
- 历史最低 1.53
- 每 手 1
- 风险率 0.59%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | AMD、Arista Networks、Booking 、加特纳、Pinterest、科力斯、Wayfair等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Precigen"买入"评级，目标价从14美元升至18美元；HC Wainwright & Co.：维持Sophia Genetics"买入"评级，目标价从12美元升至14美元
08-06 11:36
Wedbush Maintains Outperform on Larimar Therapeutics, Lowers Price Target to $11
Wedbush analyst Laura Chico maintains Larimar Therapeutics (NASDAQ:LRMR) with a Outperform and lowers the price target from $12 to $11.
08-05 21:24
Larimar Therapeutics Q2 EPS $(0.30) Beats $(0.39) Estimate
Larimar Therapeutics (NASDAQ:LRMR) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.39) by 23.08 percent. This is a 26.83 percent increase over losses of $(0.41) per share from the same period last year.
08-04 19:12
美股牛股 | 生物制药公司FBRX大涨逾78%！关键药物研究成果积极；地热电力公司FRVO股价劲升16%
生物制药公司FBRX大涨逾78%！关键药物研究成果积极；地热电力公司FRVO股价劲升16%，地热开发项目取得重要进展；贵金属概念股TXG涨15%！此前获大摩大幅上调目标价>>
07-10 19:22
Larimar Therapeutics shares are trading higher after a Form 4 filing indicated that a Director bought 50K shares at an average price of $3.34 per share.
Larimar Therapeutics shares are trading higher after a Form 4 filing indicated that a Director bought 50K shares at an average price of $3.34 per share.
07-10 02:20
美股大行评级 | Bernstein上调闪迪目标价从1700美元升至3000美元；大摩上调谷歌-A目标价从375美元升至415美元
今日重点评级关注：Citizens：维持DBV Technologies"跑赢大市"评级，目标价从47美元升至55美元；康托·菲茨杰拉德：维持BioCryst制药"超配"评级，目标价从27美元升至29美元
07-01 10:40
分析师解读医疗企业 Replimune Group（REPL）、Abivax SA 担保ADR（ABVX）及Larimar Therapeutics（LRMR）
3位医疗领域五星分析师近期分别对3只美股医疗保健个股给出看涨评级，相关核心信息如下： Replimune Group（REPL）：摩根大通将其评级上调至买入...
06-30 22:02
Baird Maintains Outperform on Larimar Therapeutics, Lowers Price Target to $5
Baird analyst Joel Beatty maintains Larimar Therapeutics (NASDAQ:LRMR) with a Outperform and lowers the price target from $7 to $5.
06-30 19:48
Why Universe Pharmaceuticals Shares Are Trading Higher By Around 228%; Here Are 20 Stocks Moving Premarket
Shares of Universe Pharmaceuticals Inc (NASDAQ:UPC) rose sharply in pre-market trading after the company announced it will acquire Best Praise International for $10.75 million. Universe Pharmaceuticals shares jumped 228.4% to $9.72 in pre-market trading. Here are some other stocks moving in pre-mark...
06-29 19:03
Larimar Advances Nomlabofusp BLA Toward Accelerated Approval
Larimar Therapeutics ( ($LRMR) ) just unveiled an announcement. On June 29, 202...
06-29 18:59
